From: Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study
 | Model 1 HR (95% CI)a | Model 2 HR (95% CI)b | Model 3 HR (95% CI)c |
---|---|---|---|
Continuous variables | |||
 BMI | 1.05 (0.96, 1.14) | 1.08 (0.99, 1.18) | 0.90 (0.75, 1.08) |
 Waist-to-hip ratio | 0.99 (0.91, 1.07) | 1.01 (0.93, 1.11) | 0.94 (0.86, 1.04) |
 Blood glucose level | 1.07 (0.98, 1.16) | 1.09 (1.00, 1.19)* | 1.09 (0.96, 1.23) |
 TC | 0.97 (0.90, 1.06) | 0.96 (0.89, 1.05) | 0.99 (0.88, 1.12) |
 HDL | 0.97 (0.90, 1.06) | 0.97 (0.89, 1.05) | 1.01 (0.92, 1.10) |
 LDL | 0.99 (0.91, 1.07) | 1.01 (0.92, 1.10) | 1.01 (0.90, 1.13) |
 TG | 1.01 (0.93, 1.10) | 1.02 (0.94, 1.11) | 0.98 (0.89, 1.08) |
 ApolA1 | 1.00 (0.92, 1.09) | 1.00 (0.92, 1.09) | 1.03 (0.95, 1.13) |
 ApolB | 1.01 (0.93, 1.10) | 1.04 (0.95, 1.13) | 1.03 (0.93, 1.14) |
Categorical variables | |||
 Waist-to-hip ratio | |||
   ≤ 0.85 | Reference | Reference | Reference |
   > 0.85 | 0.98 (0.82, 1.17) | 1.02 (0.85, 1.23) | 0.92 (0.75, 1.12) |
 Blood glucose level (mmol/L) | |||
   < 5.6 | Reference | Reference | Reference |
   ≥ 5.6 to < 7.0 | 1.05 (0.87, 1.26) | 1.08 (0.90, 1.30) | 1.03 (0.85, 1.25) |
   ≥ 7.0 | 1.17 (0.89, 1.55) | 1.28 (0.96, 1.70) | 1.18 (0.75, 1.85) |
 TC (mmol/L) | |||
  Q1 | Reference | Reference | Reference |
  Q2 | 0.92 (0.73, 1.16) | 0.93 (0.73, 1.17) | 0.93 (0.73, 1.17) |
  Q3 | 0.95 (0.76, 1.19) | 0.99 (0.79, 1.26) | 0.89 (0.61, 1.29) |
  Q4 | 0.83 (0.65, 1.05) | 0.88 (0.69, 1.12) | 0.75 (0.48, 1.18) |
 HDL (mmol/L) | |||
  Q1 | Reference | Reference | Reference |
  Q2 | 0.89 (0.70, 1.12) | 0.88 (0.70, 1.11) | 0.91 (0.72, 1.15) |
  Q3 | 0.94 (0.75, 1.18) | 0.92 (0.73, 1.16) | 1.00 (0.79, 1.26) |
  Q4 | 0.84 (0.67, 1.06) | 0.83 (0.65, 1.04) | 0.92 (0.72, 1.18) |
 LDL (mmol/L) | |||
  Q1 | Reference | Reference | Reference |
  Q2 | 0.97 (0.77, 1.22) | 0.97 (0.77, 1.22) | 0.95 (0.76, 1.21) |
  Q3 | 0.95 (0.75, 1.19) | 0.98 (0.78, 1.23) | 0.91 (0.70, 1.20) |
  Q4 | 0.86 (0.68, 1.09) | 0.92 (0.72, 1.16) | 0.82 (0.59, 1.15) |
 TG (mmol/L) | |||
  Q1 | Reference | Reference | Reference |
  Q2 | 1.04 (0.82, 1.33) | 1.06 (0.83, 1.35) | 1.04 (0.81, 1.32) |
  Q3 | 1.17 (0.93, 1.48) | 1.23 (0.97, 1.56) | 1.17 (0.91, 1.49) |
  Q4 | 1.11 (0.88, 1.42) | 1.18 (0.92, 1.51) | 1.07 (0.82, 1.41) |
 Race/Ethnicity | |||
  Black | Reference | Reference | Reference |
  White | 1.16 (0.96, 1.40) | 1.18 (0.96, 1.46) | 1.31 (1.05, 1.63)* |
 Alcohol drinking habit | |||
  Never | Reference | Reference | Reference |
  Ever | 0.96 (0.74, 1.23) | 0.93 (0.72, 1.20) | 0.91 (0.70, 1.18) |
  Current | 1.06 (0.88, 1.27) | 1.00 (0.82, 1.21) | 0.99 (0.81, 1.22) |
 Menopausal status | |||
  Postmenopause | Reference | Reference | Reference |
  Premenopause | 1.47 (1.23, 1.77)* | 1.49 (1.23, 1.79)* | 1.50 (1.24, 1.81)* |
 Education level | |||
  Below High school | Reference | Reference | Reference |
  High school/ graduate school | 0.95 (0.77, 1.17) | 0.90 (0.72, 1.12) | 0.93 (0.74, 1.16) |
  College/ graduate/ professional school | 1.08 (0.87, 1.35) | 1.02 (0.80, 1.30) | 1.09 (0.85, 1.40) |
 Income (US$/Year) | |||
   < 16,000 | Reference | Reference | Reference |
   ≥ 16,000 to < 25,000 | 1.13 (0.88, 1.46) | 1.08 (0.83, 1, 41) | 1.10 (0.84, 1.44) |
   ≥ 25,000 to < 35,000 | 0.92 (0.72, 1.17) | 0.84 (0.65, 1.09) | 0.87 (0.67, 1.13) |
   ≥ 35,000 to < 50,000 | 1.09 (0.84, 1.40) | 0.96 (0.72, 1.27) | 1.00 (0.75, 1.33) |
   ≥ 50,000 | 1.08 (0.85, 1.38) | 0.89 (0.67, 1.19) | 0.95 (0.71, 1.27) |